Related Experiment Videos
[Screening for cancer: what's new?].
1Unité d'épidémiologie pour la prévention du cancer, Centre international de recherche sur le cancer et Institut national de la santé et de la recherche médicale, 150, cours Albert-Thomas, 69372 Lyon Cedex 8, France. sasco@iarc.fr.
Bulletin Du Cancer
|April 26, 2000
Summary
Cancer screening programs, including mammography, cervical smear tests, and fecal blood testing, are proven to reduce mortality. Emerging research and new methods are expanding screening for lung and familial cancers, addressing high-genetic-risk populations.
Area of Science:
- Oncology
- Public Health
- Preventive Medicine
Context:
- Cancer screening program implementation is driven by evaluation studies and national cancer control policies.
- Established screening methods like mammography, cervical smears, and fecal blood tests demonstrate efficacy in reducing cancer mortality and incidence.
- Evolving research and emerging technologies necessitate re-evaluation of existing screening protocols and development of new approaches.
Purpose:
- To review the current landscape of cancer screening programs.
- To discuss the evidence supporting established screening methods for breast, cervical, and colon cancers.
- To explore emerging challenges and future directions in cancer screening, including new technologies and high-risk populations.
Summary:
- Mammographic screening reduces breast cancer mortality in women aged 50+, cervical smear screening impacts cervical cancer, and fecal blood testing aids in colon cancer mortality reduction.
- Re-evaluation of breast cancer screening before age 50 and the development of lung cancer screening methods are ongoing.
- Addressing genetic predispositions for familial breast and ovarian cancers requires tailored screening strategies.
- Methodological challenges in rapidly generating evidence for screening necessitates innovative approaches beyond traditional randomized controlled trials.
Impact:
- Provides a comprehensive overview of the benefits and challenges associated with various cancer screening modalities.
- Highlights the importance of national policies and evidence-based evaluation in establishing effective cancer screening programs.
- Emphasizes the need for continuous research and adaptation of screening strategies to address evolving scientific knowledge and public health needs.